Cardiovascular Risk Clinical Trials in Minneapolis, Minnesota
2 recruitingMinneapolis, Minnesota
Showing 1–2 of 2 trials
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Blood PressureNeuropathyDiabetes+6 more
Jaeb Center for Health Research200 enrolled18 locationsNCT06837181